Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950134-04-007637
Filing Date
2004-05-14
Accepted
2004-05-14 16:10:11
Documents
3
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FROM 10-K d14793a2e10vkza.htm 10-K/A 167027
2 CERTIFICATION OF CEO AND CFO d14793a2exv31w1.htm EX-31.1 13571
3 CERTIFICATION OF CEO AND CFO d14793a2exv32w1.htm EX-32.1 4344
  Complete submission text file 0000950134-04-007637.txt   186709
Mailing Address 301 CONGRESS AVE SUITE 1850 AUSTIN TX 78701
Business Address 301 CONGRESS AVE SUITE 1850 AUSTIN TX 78701 5127089310
INTROGEN THERAPEUTICS INC (Filer) CIK: 0001018710 (see all company filings)

EIN.: 742704230 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-21291 | Film No.: 04807926
SIC: 2834 Pharmaceutical Preparations